Publications

Below are publications related to our programs and/or our affiliated researchers.

• International Cannabinoid Research Society Conference, Jerusalem, Israel, June 20-24, 2021
  • CANCER APPETITE RECOVERY STUDY (CARES): STUDY PROTOCOL FOR A DOSE-ASCENDING, MULTICENTER, RANDOMIZED CONTROLLED PHASE 1/2 TRIAL OF ART27.13 IN PATIENTS WITH CANCER ANOREXIA AND WEIGHT LOSS (Click to Open, PDF, 4MB)
  • THE EFFECTS OF CBD AND TMP COADMINISTRATION IN CANCER (Click to Open, PDF, 285KB)
• Carbonetti, G et. al., Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth. Prostate. 2019 Oct 29. doi: 10.1002/pros.23921 (Click to Open, PDF, 2.5MB)
• Carbonetti, G et. al., Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth. Prostate. 2019 Oct 29. doi: 10.1002/pros.23921 (Click to Open, PDF, 2.5MB)
• Millar SA, Stone NL, Yates AS, O'Sullivan SE. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front Pharmacol. 2018;9:1365. Published 2018 Nov 26. doi:10.3389/fphar.2018.01365 (Click to View Online)
• Su Yan et. al., SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins, European Journal of Medicinal Chemistry, Volume 154, 2018, Pages 233-252, ISSN 0223-5234, https://doi.org/10.1016/j.ejmech.2018.04.050 (Click to View Online)